Published in Women's Health Weekly, May 18th, 1998
Long considered incurable, scleroderma has no generally accepted successful treatment.
Speaking in Boston, Massachusetts, at the 6th Biennial Congress of the International Society for Rheumatic Therapies, David E. Trentham, MD, principal investigator of the study, announced that minocycline had dramatic effects on 11 patients with early but severe disease. In just one year, 82 percent of participants improved significantly, with 66 percent of those who completed the study in...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly